Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Arrowhead Pharmaceuticals Inc. buy JPMorgan Chase & Co.

Arrowhead Pharmaceuticals Inc.
Start price
€64.96
17.07.26 / 50%
Target price
€83.05
17.07.27
Performance (%)
16.72%
Price
€75.82
07.08.26
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ currently has a performance of 16.72%. This prediction currently runs until 17.07.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Arrowhead Pharmaceuticals Inc. 3.269%
iShares Core DAX® 2.573%
iShares Nasdaq 100 4.858%
iShares Nikkei 225® 5.590%
iShares S&P 500 3.250%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 16.72%
Target price 83.049
Change
Ends at 17.07.27

Arrowhead Pharmaceuticals (ARWR) had its price target raised by JPMorgan Chase & Co. from $88.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for ARWR provided by MarketBeat

JPMorgan Chase & Co. 
1
Report Share
17.07.26